| Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma SP Caragher, JM Shireman, M Huang, J Miska, F Atashi, S Baisiwala, ... Journal of Neuroscience 39 (11), 1982-1993, 2019 | 80 | 2019 |
| Chemotherapeutic stress induces transdifferentiation of glioblastoma cells to endothelial cells and promotes vascular mimicry S Baisiwala, B Auffinger, SP Caragher, JM Shireman, R Ahsan, G Lee, ... Stem cells international 2019, 2019 | 46 | 2019 |
| De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma JM Shireman, F Atashi, G Lee, ES Ali, MR Saathoff, CH Park, S Savchuk, ... Brain 144 (4), 1230-1246, 2021 | 39 | 2021 |
| LNX1 modulates Notch1 signaling to promote expansion of the glioma stem cell population during temozolomide therapy in glioblastoma S Baisiwala, RR Hall III, MR Saathoff, J M. Shireman, C Park, S Budhiraja, ... Cancers 12 (12), 3505, 2020 | 12 | 2020 |
| CRISPR-Cas9 Screen Reveals PSMB3 Contributes to Gliomagenesis Through Proteasome-Dependent and Independent Mechanisms S Baisiwala, S Budhiraja, AJ Zolp, K Nandoliya, L Chen, CH Park, ... bioRxiv, 2021.07. 28.453566, 2021 | 1 | 2021 |
| Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells’ Role in Tumor Progression S Baisiwala, S Budhiraja, C Goel, KR Nandoliya, MR Saathoff, AU Ahmed Stem cell reviews and reports, 1-13, 2021 | 1 | 2021 |
| OS6. 1 Targeting Purine Metabolism to Overcome Therapeutic Resistance in Glioblastoma AU Ahmed, J Shireman, F Atashi, M Saathoff, E Ali, G Lee, C Park, ... Neuro-Oncology 21 (Supplement_3), iii12-iii12, 2019 | 1 | 2019 |
| ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM S Budhiraja, G McManus, S Baisiwala, EN Perrault, S Cho, M Saathoff, ... Neuro-Oncology, noae059, 2024 | | 2024 |
| Abstract PR011: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM AU Ahmed, JM Shireman, F Atash, G Lee, ES Ali, MR Saathoff, CH Park, ... Cancer Research 82 (10_Supplement), PR011-PR011, 2022 | | 2022 |
| Abstract B034: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM AU Ahmed, JM Shireman, F Atash, G Lee, ES Ali, MR Saathoff, CH Park, ... Cancer Research 82 (10_Supplement), B034-B034, 2022 | | 2022 |
| DDRE-27. LMNA-PRKDC AXIS PROMOTES CHEMORESISTANCE IN RECURRENT GBM BY STABILIZING DNA REPAIR FOCI M Saathoff, J Shireman, S Savchuk, S Baisiwala, C Park, C James, ... Neuro-Oncology 22 (Suppl 2), ii67, 2020 | | 2020 |
| CBIO-17. IDENTIFYING A NETWORK OF ESSENTIAL & TUMORIGENIC GENES IN GLIOBLASTOMA USING WHOLE-GENOME CRISPR Cas9 SCREENING S Baisiwala, M Saathoff, C Dmello, J Shireman, L Chen, C Park, C Awah, ... Neuro-Oncology 22 (Supplement_2), ii19-ii19, 2020 | | 2020 |
| Identifying a novel network of driver genes in glioblastoma S Baisiwala, C Park, C Awah, JM Shireman, MR Saathoff, A Sonabend, ... Cancer Research 80 (16_Supplement), 197-197, 2020 | | 2020 |
| 44. EFFECT OF STEREOTACTIC RADIOSURGERY ON NON-SMALL CELL LUNG CANCER BRAIN METASTASIS: CONTINUED CORRELATIVE RADIOBIOLOGIC ANALYSIS OF DNA AND RNA GENOMIC PROFILES FROM PHASE … M Henriquez, W Huff, J Shireman, G Monaco, N Agrawal, CH Park, ... Neuro-oncology Advances 2 (Suppl 2), ii8, 2020 | | 2020 |
| DRES-09. REGULATORY EFFECTS OF THE CILIARY GTPASE ARL13B ON PURINE METABOLISM IN GBM M Saathoff, J Shireman, E Ali, C Park, I Ben-Sahra, A Ahmed Neuro-oncology 21 (Suppl 6), vi73, 2019 | | 2019 |
| BSCI-19. EFFECT OF STEREOTACTIC RADIOSURGERY ON NON-SMALL CELL LUNG CANCER BRAIN METASTASIS: CORRELATIVE RADIOBIOLOGIC ANALYSIS FROM PHASE-II CLINICAL TRIAL NCT03398694 W Huff, J Shireman, G Monaco, N Agrawal, C Park, M Saathoff, ... Neuro-oncology Advances 1 (Suppl 1), i4, 2019 | | 2019 |
| ARL13B interacts with IMPDH2 to modulate purine synthesis and temozolomide resistance in glioblastoma J Shireman, E Ali, M Saathoff, C Park, I Ben-Sahra, AU Ahmed Cancer Research 79 (13_Supplement), 81-81, 2019 | | 2019 |
| DRES-11. EPIGENETIC REGULATION OF TUMOR SUPPRESSOR GENE HOXD10 DURING ANTI-GLIOMA CHEMOTHERAPY HUO BARCODING Neuro-oncology, 2017 | | 2017 |
